Organs targeted by ACE-2-utilizing viruses like COVID-19

This infographic from Scientist illustrating the many organs that the virus can gain entry to using ACE2 or TMRPSS2 receptors (definitive evidence for viral presence in the various organs is still being established, but the presence of the receptors provides a road map for investigation). Certainly this influences the wide variety of COVID presentations we…

Can Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity?

ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS coronavirus 2, or SARS-CoV-2) is the cause of the respiratory infection known as COVID-19. From an immunopathological standpoint, coronaviruses such as SARS-CoV-2 induce increased levels of a variety of T-helper 1 (Th1) and inflammatory cytokines and chemokines, including interleukin-1 (IL-1), IL-6, CCL2 protein, and CXCL10 protein. In…

The Functional Medicine Approach to COVID-19: Additional Research on Nutraceuticals and Botanicals

In this paper, the Institute for Functional Medicine (IFM) added to the list of nutraceuticals and botanicals introduced earlier in their first article, The Functional Medicine Approach to COVID-19: Virus-Specific Nutraceutical and Botanical Agents. Periodically, IFM will update the original list to highlight other agents that may be considered as complementary treatments against COVID-19. Along…

New COVID-19 Peer-Reviewed Publication – Natural Interventions for All Four Phases of the COVID Disease Lifecycle

I am honored to have contributed to this important publication on interventions for all four potential phases of COVID-19 – prevention, infection, inflammation and recovery. In this paper, intended for healthcare professionals, we address: Five key support targets: foundation, Natural Killer cell support, T Helper Type 1 cell support, Anti-inflammatory Support, Anti-Oxidant Support Why underlying…

COVID-19 Illness in Children

“Mysterious” COVID-19 Illness in Children – Not Such a Mystery After All by Dr. Bird

Many of you have reached out over the past few days with questions about recent reports in the press about a “mysterious” inflammatory condition associated with COVID-19 among children. Indeed, there is an apparent uptick in the incidence of what is now being called “pediatric multisystem inflammatory syndrome potentially associated with COVID-19” (PIMS).  Though dubbed by the press as mysterious, it is an illness that shares features with several well-known pediatric inflammatory syndromes (most notably Kawasaki Disease and Toxic Shock) and there is widespread consensus in the pediatric community as to what early identification and treatment should look like. 

Strategies for getting the country back to work while minimizing harm – Smart thinking from Dr. David Katz

If I could choose the path that balances the opposing economic and health drivers of social distancing and isolation, this would probably be it. Dr. David Katz outlines a very smart approach that could at least be applied to future pandemics, if not also to our planning for COVID-19 relaxation of lockdown measures.